Rôle pronostique des emboles vasculaires tumoraux dans les tumeurs des voies excrétrices urinaires supérieures : analyse rétrospective monocentrique

[1]  O. Cussenot,et al.  The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). , 2013, Urologic oncology.

[2]  M. Dimopoulos,et al.  Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC) , 2011, Cancer.

[3]  C. Kwak,et al.  Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract. , 2011, Urologic oncology.

[4]  M. Babjuk,et al.  European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. , 2011, European urology.

[5]  H. Quintens,et al.  Recommandations en Onco-Urologie 2010 : Tumeurs urothéliales , 2010 .

[6]  S. Shariat,et al.  Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. , 2010, European urology.

[7]  H. Quintens,et al.  [Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology]. , 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[8]  F. Montorsi,et al.  Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma , 2010, BJU international.

[9]  A. Finelli,et al.  Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. , 2009, Urology.

[10]  N. Cho,et al.  Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. , 2009, Urology.

[11]  A. Kibel Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma , 2009 .

[12]  F. Montorsi,et al.  Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. , 2009, European journal of cancer.

[13]  K. Bensalah,et al.  Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. , 2009, The Journal of urology.

[14]  V. Margulis,et al.  Adjuvant chemotherapy for high-risk upper tract urothelial carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P. Alken,et al.  Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis , 2009, BJU international.

[16]  K. Kihara,et al.  Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. , 2008, The Journal of urology.

[17]  F. Ito,et al.  Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. , 2005, Urology.

[18]  C. Kwak,et al.  Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. , 2006, Urology.

[19]  Yair Lotan,et al.  Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy , 2005 .

[20]  C. Roehrborn,et al.  Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. , 2004, The Journal of urology.

[21]  T. Carmody,et al.  Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. , 1998, Urology.

[22]  J. Chmiel,et al.  Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee. , 1992, Urology.